Author: Serkadis

Lee Scott, former president and CEO of Wal-Mart, has joined Solamere Capital as an operating partner and member of the firm’s investment committee. He had joined Wal-Mart in 1979 as an assistant director in the company’s logistics division, and served as president and CEO for nine years until leaving this past February.

PRESS RELEASE

Lee Scott, former Wal-Mart CEO, has joined the private equity firm Solamere Capital as an Operating Partner and as a member of its Investment Committee. Mr. Scott will assist Solamere Capital in the evaluation of investment opportunities and will play a key role in contributing to the growth of its portfolio companies.

“I am excited to be working with Solamere’s management team and founding investors,” said Lee Scott. “I believe that Solamere Capital and its network of partners are uniquely positioned to help a broad range of businesses add topline growth. I am encouraged about Solamere’s distinctive approach to private equity and I am looking forward to being a part of the long-term development of this firm.”

“Lee’s leadership experience and his ability to identify growth opportunities will greatly benefit our investors, partner funds and future portfolio companies by adding substantial value to our investment process. We are honored to be working with Lee in this capacity,” said Managing Partners Tagg Romney, Eric Scheuermann and Spencer Zwick and Operating Partner John Miller in a joint statement.

Lee Scott is chairman of the executive committee of the Board of Directors of Wal-Mart Stores, Inc. From January 2000 to February 2009, he served as president and CEO of Wal-Mart. Mr. Scott joined Wal-Mart in 1979 as an assistant director in the Logistics division, rising through the ranks to executive vice president of Logistics in 1993 and executive vice president of Merchandise in 1995. He became president and chief executive officer of the Wal-Mart U.S. division in 1998, chief operating officer and vice chairman for the corporation in 1999, and president and CEO in 2000.

Mr. Scott is a native of Baxter Springs, Kansas, and resides in Rogers, Arkansas, with his wife Linda.

About Solamere Capital:
Solamere Capital was founded to serve as a unique investment vehicle for a small number of families and industry leaders with broad networks that aspired to aggregate their access to top-tier private equity firms, proprietary deal flow, management resources and industry insight.

ShareThis

The much-awaited version 7 of Autonomy/Interwoven TeamSite finally seems to have been released by Autonomy. While we will cover the details shortly for our Web Content Management subscribers, the key changes come in a new Unified Administration Console for TeamSite and OpenDeploy, enhanced UI features including the ability to do in-context editing in a wiki-like fashion, and various other improvements. Autonomy has also deprecated Crystal Reports (a bummer, since some customers spent real money there) as well as iLog JRules. There’s a substantial new emphasis on employing Autonomy IDOL throughout, including as a persistence tier for LiveSite. So if you are upgrading, these changes will impact you.

I say "seems to have been released" because Autonomy has been strangely quiet about it. Typically, when vendors release a new product or a major upgrade, there’s a lot of noise: press releases, demos, conferences and so on. Nothing of this sort happened when Autonomy released upgrades to version 7.0 of TeamSite, LiveSite, and OpenDeploy.  This is not typical of Autonomy Marketing and so the question emerges….have they actually released it? The new version is available, but many customers as well as partners aren’t even aware of it.

So whether you are a prospective customer planning to evaluate new products or an existing customer planning an upgrade, we would recommend that instead of moving to a dot zero release you hold on for a while or at least till the next point release of version 7 is announced. We’ll have more to share in the coming months with our research subscribers.

Following on from the popular Droid Does and Stealth commercials, Verizon have added another three tv commercials to their YouTube channel.

Unlike the first two ads, these new commercials focus more on the Android platform and its functionality. These new ads are expected to air across the US soon.

The Motorola Droid is now available from Verizon priced at priced at $199 as part of a 2-year service contract.

If you’re looking for more info on the new Verizon Android phones, then be sure to check out Droid Forums & Droid Eris Forums

3 New Verizon Droid TV Commercials

Many countries are pouring millions into orders for swine flu vaccine from pharmaceutical companies. But one country is taking a different approach.
The Irish Independent reports that the some Canadian provinces have suspended the ‘normal’ seasonal flu shots for anyone under 65 in response to a recent study there. However, the vaccine suspensions do not apply for people over 65.
The study suggests that people vaccinated against seasonal flu are actually twice as likely to catch swine flu.
But plans vary across the provinces of Canada. Last month, British Columbia announced it is suspending seasonal flu shots for anyone under 65 years old, joining Quebec, Alberta, Saskatchewan, Ontario and Nova Scotia in halting the immunizations.
Quebec’s Health Ministry announced it would postpone vaccinations until January, clearing the autumn months for health professionals to focus on vaccinating against H1N1, which is expected to the more severe influenza strain this season.
“By the time the H1N1 wave is over, there will be ample time to vaccinate for seasonal flu,” said Dr. Ethan Rubinstein, head of adult infectious diseases at the University of Manitoba.
Other provinces, including Manitoba, are still pondering a response to the research. New Brunswick, one of the lone holdouts, made an announcement in September that it would forge ahead with seasonal flu shots for all residents in October, as originally planned.
Yet according to an even more recent posting by PreventDisease.com, some provinces are still recommending co-administration of both vaccines in as little as 60 days, according to a staggered schedule.
An international panel is currently scrutinising the controversial study’s data. Dr Ethan Rubinstein, who has read the study, said it appeared sound.
“There are a large number of authors, all of them excellent and credible researchers,” he said. “The sample size is very large, at 12 or 13 million people.”
It was back in 1981 that R. Edgar Hope Simpson proposed that a principal cause of seasonal influenza is linked with the deficiency of solar radiation which triggers the production of vitamin D in the skin. Vitamin D deficiency is common in the winter, and vitamin D is crucial in allowing your immune system to defend itself against invading organisms.
In addition to vitamin D, studies have suggested that people who exercise moderately suffer fewer and less severe colds and flu infections.
In a new study, researchers found that when they had a group of mice regularly run on a treadmill over 3.5 months, the animals developed less-severe symptoms when infected with the flu virus.
Additionally, mice that exercised right before flu infection, but not regularly over the preceding months, also showed some protection against severe symptoms — which in mice means dampened appetite and weight loss. Those benefits, however, were only apparent in the couple days after infection, whereas regular long-term exercise reduced flu symptoms over the whole course of infection.

From: Swine Flu

Erik was the first of a bunch of you to send in the story about how BMW is supposedly applying for a patent on a method using technology to solve problems. You can read the patent application for a Method for Systematically Identifying Technology-Based Solutions if you’d like. It’s not quite as broad as the claim on Autoblog that it’s a patent application on “technological creative thinking,” but it is ridiculously broad. Read through the actual claims, and it’s difficult to see how this deserves a patent at all. There shouldn’t be a monopoly on a method for how you solve problems.

Permalink | Comments | Email This Story

KDDI did it as early as last month, and today it was NTT Docomo’s and SoftBank’s turn to unveil their line-ups of new cell phones for the Japanese market. Here are all of SoftBank’s 17 future models [JP], which will be sold in Japan from this fall through spring 2010.

After many attempts to block or delay the release of info on who lobbied the federal government last year for telco immunity in lawsuits involving the fed’s warrantless wiretapping program, the government has finally agreed to hand over some of the information requested. Of course, since the administration had already won a longer delay, and only some of the info is being revealed, I’m guessing that there isn’t much surprising in what’s being released — though it makes you wonder why the administration went to such lengths to hide it.

Permalink | Comments | Email This Story

GamersGate has a virtual currency I might actually want to earn
Excellent idea: flat outlet pulls out to allow extra plug
USB-powered gloves that keep your fingers warm (but why?)
Finally, Roombas enacting a game of Pac-Man
Star Trek Blu-ray release earns a perfect score at Blu-ray.com
Trillions: a short film on the future of computing

(NaturalNews) Until early 2009, Silk brand soy milk was made using organic soybeans. But earlier this year, Dean Foods (owner of the Silk brand) quietly switched to conventional soybeans, which are often grown with pesticides. But they kept the same UPC barcodes on their products, and they kept the product label virtually the same, only replacing the word “organic” with “natural” in a way that was barely noticeable. They also kept the price the same, charging consumers “organic” prices for a product that was now suddenly made with conventionally-grown soybeans.

Many retailers and consumers never noticed the bait-and-switch tactic, so they kept buying Silk, thinking it was still organic. The shift on the product label from “organic” to “natural” wasn’t well understood by consumers, either. Many consumers continue to think that the term “natural” is basically the same as “organic,” when in fact they are almost opposites. The term “natural” is entirely unregulated, and almost anything can be claimed to be “natural” even when it’s sprayed with pesticides or treated with other chemicals.

This bait-and-switch ploy continued throughout 2009 until a few watchdog organizations started to catch on to the covert switch. In late October, the Cornucopia Institute (www.Cornucopia.org) accused Target stores of misleading consumers by advertising Silk products using the old “organic” labeling even though the product being sold in stores was not organic. Cornucopia’s Mark Kastel accused Target and Dean Foods for “blurring the line between organic and natural,” thereby confusing consumers while boosting profits from the more lucrative sales of non-organic products sold at organic prices. (http://www.cornucopia.org/2009/10/off-target-major-retailer-accused-of-organic-improprieties-state-and-federal-complaints-allege-mislabeling/)

Meanwhile, a Sunflower health food store in Texas also found itself caught up in the bait-and-switch tactic. It had been reordering Silk for months, thinking the product was still organic. But now, after discovering the scam, the store posts a hand-written sign in front of the Silk products, warning consumers with this message: “Silk is no longer organic.”

“We don’t want to be part of customer deception,” said the store owner in a Star-Telegram interview.

According to that same story, food retailers in California, Delaware and Texas were also duped by Silk’s bait-and-switch scheme, only discovering the switch to conventional soybeans months after the switch was covertly made. Dean Foods, you see, never bothered to tell retailers they had switched from organic to conventionally-grown soybeans. They just quietly made the switch but kept the same box design and UPC codes, perhaps hoping no one would notice. And the ploy worked!

“Dean has only added to the marketplace confusion between ‘natural’ and ‘organic,’ as they definitely do not mean the same thing, and ‘natural’ requires no verification whatsoever,” said Consumer Reports senior scientist Urvashi Rangan (see Star-Telegram article link below).

Labeling deception
Dean Foods is one of the big food giants that serves processed, factory-made foods and beverages to the American people. It’s the parent company of Horizon Organic, the so-called “organic” milk maker that’s been caught up in a web of deception exposed by the Organic Consumers Association (http://www.naturalnews.com/021763_organic_standards_organic_milk_Dean_Foods.html).

The company has pushed hard to lower organic standards so that it could market products as “organic” even though they might contain questionable ingredients. When Dean Foods bought out WhiteWave, the creator of Silk soy milk, WhiteWave founder Steve Demos soon left the company in disgust, saying that “green” values had been abandoned for the sake of profit.

Dean Foods even refused to participate on a “soy scorecard” investigation undertaken by the Cornucopia Institute (http://www.naturalnews.com/026294_soy_food_foods.html). The last thing this company wants is scrutiny of its business practices, it seems. For example, in 2002, Dean Foods cut off U.S. soybean farmers and switched to soybeans grown in China (http://www.cornucopia.org/silk-whitewavedean-foods/). And for years, the company has waged attacks on the Cornucopia Institute itself.

In my opinion, Dean Foods is the Enron of the food industry. It has no ethics, no moral code and no hesitation about deceiving consumers or hurting American farmers in order to maximize profits.

In America today, the big food companies are all about disinforming consumers. Rather than telling the truth on product labeling, they seek to confuse consumers with misleading information. That’s why they want to weaken the definition of “organic” — so that they can essentially grow conventional foods with pesticides, then misleadingly position them as “near-organic” products that are sold at organic prices.

Consumers end up buying products they think are organic but really aren’t. And because the products are misleadingly positioned as “organic” products, they command a higher price. This, in turn, generates more profits for the food companies.

Lying about being organic pays well in the food industry today. Perhaps that’s why so many companies continue to do it.

Dean Foods facts
From: http://www.sourcewatch.org/index.php?title=Dean_Foods_Company

• Dean Foods investors include Pfizer, ExxonMobil, Coca-Cola and Wal-Mart.

• Dean Foods controls 70% of all “organic” milk products sold in the U.S.

• Dean Foods brands include Hershey’s, Folgers, Borden, Horizon milk, Stroh’s ice cream and Silk soy milk.

• Dean Foods spent over $1 million on lobbyists in 2006.

• The CEO of Dean Foods, Gregg Engles, was paid $3.4 million in salary and nearly $58 million in exercised stock options in 2006 alone.

Additional sources for this story include:

Cornucopia Target complaint (PDF)
http://www.cornucopia.org/USDA/TargetComplaint_10-09.pdf

Star-Telegram
http://www.star-telegram.com/local/story/1746193.html

(NaturalNews) High intake of foods containing the natural plant compound apigenin might decrease a woman’s risk of ovarian cancer, researchers from Brigham and Women’s Hospital and Harvard Medical School have found.

Apigenin is a class of flavonoid, a phytonutrient (plant compound) family known for its high antioxidant activity. Antioxidants are renowned for removing cell-damaging free radicals from the body, thereby reducing the symptoms of aging and the risk of chronic disease such as cancer and heart disease.

Foods high in apigenin include celery, parsley, tomato sauce and red wine. The compound is widely believed to be safe when consumed in plant foods, with no toxic or mutagenic effects.

In a study funded by the National Cancer Institute and the National Institutes of Health, and published in the International Journal of Cancer, researchers gave questionnaires to 1,141 ovarian cancer patients and 1,183 women of similar age to assess the content of their diets over the course of one week. The average participant age was 51. Women with ovarian cancer were more likely to be heavier and have a higher daily calorie intake, with a less healthy diet than the healthy women.

The researchers used the questionnaires to calculate the participants’ intake of five different, common flavonoids: apigenin, kaempferol, luteolin, myricetin and quercetin. The bulk of these antioxidants in the women’s diets came from tea, red wine, apples, blueberries, celery, kale, lettuce, oranges and tomato sauce.

Higher intake of certain rich-rich foods such as cauliflower, raisins and tomato sauce was associated with a decreased risk of ovarian cancer, though this correlation was not statistically significant. There was no correlation between total flavonoid consumption and cancer risk after adjusting for known cancer risk factors such as age, physical activity, use of oral contraceptives, and history of childbirth, breastfeeding and tubal ligation. There was also no correlation between cancer risk and any of the flavonoids except for apigenin.

Women with the highest apigenin intake, however, had a “borderline significant” 28 percent lower risk of ovarian cancer than women with the lowest intake, after adjusting for other risk factors and intake of the other four flavonoids.

Ovarian cancer is among the most lethal forms of cancer in women. There are 20,000 new cases in the United States each year, leading to 15,000 deaths per year. According to the Ovarian Cancer National Alliance, the disease affects one in 69 women and kills one in 95.

This study is not the first to indicate a connection between apigenin and decreased cancer risk. Previous research has found that apigenin decreases the structural stability and inhibits the expression of a protein that is involved in the migration of ovarian cancer cells to other parts of the body. It has also been more directly observed to interfere with the movement of ovarian cancer cells. Apigenin has also been shown to inhibit the expression in ovarian cancer cells of a protein linked to the development of blood vessels in tumors, as well as overall tumor growth.

Other studies have found that apigenin inhibits the growth of some breast cancers and may induce programmed cell death. Higher intake of other flavonoids has also been shown to reduce the risk of ovarian cancer.

The researchers in the current study speculated that flavonoids may also help reduce ovarian cancer risk simply by functioning as antioxidants, eliminating free radicals that have been linked to DNA damage. More specifically, apigenin and other flavonoids might inhibit the effect of estrogen in the body either by reducing circulating levels or by blocking estrogen receptors.

“These mechanisms could be important in inhibiting ovarian carcinogenesis, due to the estrogen-rich environment within the ovaries and the proliferative effect of estrogen on ovarian epithelial cells,” the researchers wrote.

Sources for this story include: www.reuters.com; www.nutraingredients.com.

(NaturalNews) The results of the decade-long Interphone study on cell phone safety are that heavy cell phone use increases the risk of developing brain tumors later in life. The study, which focused on three types of brain cancer and tumors of the parotid gland, found a significant increase in cancer after a decade or more of cell phone use.

When a cell phone tower connects with a cell phone, electromagnetic radiation is created. When the cell phone is held against the ear, this radiation penetrates the brain, particularly in children.

According to the Daily Telegraph in London, the World Health Organization (WHO) will soon publish the results of the Interphone study, which was conducted in 12 countries by the International Agency for Cancer Research (IARC).

Head researcher Dr. Elisabeth Cardis told the Telegraph, “In the absence of definitive results and in the light of a number of studies which, though limited, suggest a possible effect of radio frequency radiation, precautions are important. I am therefore globally in agreement with the idea of restricting the use by children, though I would not go as far as banning mobile phones as they can be a very important tool, not only in emergencies, but also maintaining contact between children and their parents and thus playing a reassurance role. Means to reduce our exposure (use of hands-free kits and moderating our use of phones) are also interesting.”

These results from the Interphone study follow closely on research published in the Oct 13 issue of the Journal of Clinical Oncology, which reviewed existing research on the association between cell phones and brain tumors. It found that when just the well-done studies were included, there was an 18% increased risk of brain tumors in cell phone users, and that they tended to occur on the side of the head that the cell phone was used most.

In the United States, which did not participate in the Interphone study, there are 270 million cell phones in use. Senator Tom Harkin, now head of the Senate Health, Education, Labor and Pensions Committee, has promised to probe more deeply into the question of a link between cell phones and brain cancer.

There’s no argument that cell phones emit an electromagnetic field, a form of microwave radiation, that enters the brain when the cell phone is held against the ear, and there’s good research showing that the field does affect brain function. Although research has not shown that short term cell phone use causes cancer, a large population study from Sweden has shown that people who use cell phones for more than ten years on the same side of the head have a 40% higher risk of certain types of brain tumors. The Interphone study adds to this evidence.

Cell phone users can distance the brain from electromagnetic fields by using the speaker phone function, a headset, or by texting.

Sources:

“Long-term use of mobile phones may be linked to cancer,” by Martin Beckford and Robert Winnett, Daily Telegraph, London, 24 Oct 2009: http://www.telegraph.co.uk/technology/mobile-phones/6420093/Long-term-use-of-mobile-phones-may-be-linked-to-cancer.html

“Cancer Cell Phone,” by Tom Pettifor, Mirror.co.uk News, Oct 26, 2009: http://www.mirror.co.uk/news/top-stories/2009/10/26/cancer-cell-phone-115875-21774016

“Mobile Phone Use and Risk of Tumors: A Meta-Analysis,” Seung-Kwon Myung, Woong Ju, Diana D. McDonnell et al, Journal of Clinical Oncology, published online October 13, 2009, DOI:10.1200/JCO.2008.21.6366

About the author

http://www.virginiahopkinstestkits.com

Virginia Hopkins is a best-selling author and co-author of books about women’s hormones, nutrition, prescription drugs and more, including What Your Dr. May Not Tell You About Menopause with Dr. John Lee, and Prescription Alternatives.

Virginia is currently editor of the Virginia Hopkins Health Watch newsletter, at http://www.virginiahopkinstestkits.com/hopkinshealth.html

(NaturalNews) Dr. Mehmet Oz is a huge promoter of vaccines. He’s been on television reinforcing fear about H1N1 swine flu and telling everyone to get vaccinated. But what he didn’t tell his viewing audience is that he holds 150,000 option shares in a vaccine company that could earn him millions of dollars in profits as the stock price rises. It is in Dr. Oz’s own financial interest, in other words, to hype up vaccines and get more people taking them so that his own financial investments rise in value.

Evidence describing these facts was delivered to NaturalNews by a private investigator. That evidence includes an SEC document detailing how Dr. Oz. bought options on stocks for SIGA Technologies in 2005, 2007, 2008 and 2009. SIGA Technologies (stock symbol SIGA) is a vaccine technology company with many advanced developments whose success depends on the widespread adoption of vaccines. According to SEC documents, Dr. Mehmet Oz. currently holds 150,000 option shares on SIGA Technologies, purchased for as little as $1.35 back in 2005.

At the time of this writing, SIGA Technologies is trading at $7.10, making those options bought in 2005 worth $5.75 in profits today. If all the 150,000 options purchased by Dr. Oz. were exercised today, they would be worth roughly $180,000 in profits (they were bought at different prices, not all at $1.35). This is all revealed in what the SEC website calls an “insider transaction” document (link below).

These options won’t expire until the years 2015 – 2019, and the higher the stock price of SIGA gets before then, the more profit can be realized when these options are cashed out. You can see the 2019 expiration date in this “insider transaction” form: http://sec.gov/Archives/edgar/data/1010086/000114036109012259/xslF345X03/doc1.xml

If the stock price of SIGA Technologies could be pumped up even more — say, from someone hyping up vaccines in front of a national audience — these options could mathematically be worth millions of dollars.

Dr. Oz. isn’t merely a holder of SIGA stock options, by the way: He’s on the Board of Directors! As SIGA’s own website explains, Dr. Oz has served on the board since 2001 and continues his role there today. This brings up the obvious question:

Is it right for someone talking about whether vaccines are safe on television to also be carrying stock options and serving on the board of directors of a vaccine company at the same time?

Just to make things a little more interesting, SIGA Technologies recently received a $3 million grant in taxpayer dollars from the National Institutes of Health (NIH). The purpose of the grant money? To fund the study of a chemical adjunct named ST-246 to be used in future vaccines. So taxpayer money is now being used to fund a vaccine technology company whose stock price increases will financially benefit the very celebrity doctor who is hyping up vaccines to a national audience.

Something sounds fishy here…

Conflict of interest?
To my knowledge, Dr. Oz. has never disclosed to his viewing audience the fact that he owns 150,000 option shares of SIGA Technologies. And yet, with an audience of millions, Dr. Oz has continued to beat the drum of the vaccine industry, urging people to get vaccinated while implying that vaccines protect people from swine flu (even though there is absolutely no scientific evidence to back up that claim).

Here’s a link to the SEC document detailing Dr. Oz’s ownership of these 150,000 option shares:
http://sec.gov/cgi-bin/own-disp?action=getowner&CIK=0001139299&sortid=period-of-report-ASC

The current value of SIGA shares can be verified here:
http://finance.yahoo.com/q?s=SIGA

Information about SIGA Technologies and their vaccine technology can be found on their website:
http://www.siga.com/index.php?ID=2

The press release announcing SIGA’s receipt of $3 million from the NIH is available here:
http://www.siga.com/?ID=120

The RealAge Big Pharma front group
In addition to holding stock options in a vaccine technology company, Dr. Oz. is also a front man for the RealAge website, a sort of “health front group” for the pharmaceutical industry that uses information provided by RealAge members to solicit consumers with pro-pharma marketing message targeted by age or health condition.

Corporate sponsors of RealAge include most of the major drug companies and their most profitable pharmaceutical products such as Adderall, Ambien and Celebrex. The companies sponsoring RealAge include GlaxoSmithKline, Genentech, Wyeth and many others. RealAge is essentially a marketing platform for Big Pharma, disguised to look like a consumer health information service.

The New York Times calls RealAge “a window for drug makers” (http://www.nytimes.com/2009/03/26/technology/internet/26privacy.html?_r=2&scp=2&sq=dr.%20oz&st=cse) and explains, “The test has received widespread publicity because of its affiliation with Dr. Mehmet Oz.”

This NY Times article goes on to explain how the RealAge scheme operates:

People come to the site, then provide an e-mail address to take [the RealAge test]. They are asked throughout the test if they would like a free RealAge membership. If people answer yes to any of the prompts, they become RealAge members, and their test results go into a marketing database.

RealAge allows drug companies to send e-mail messages based on those test results. It acts as a clearinghouse for drug companies, including Pfizer, Novartis and GlaxoSmithKline, allowing them to use almost any combination of answers from the test to find people to market to, including whether someone is taking antidepressants, how sexually active they are and even if their marriage is happy.

RealAge sends the selected recipients a series of e-mail messages about a condition they might have, usually sponsored by a drug company that sells a medication for that condition.

The RealAge ads seen all over the internet do not openly disclose that taking the RealAge test gets you signed up to be solicited by Big Pharma for medication advertisements. Dr. Oz’s continued promotion of this service has exposed tens of millions of health consumers to this deceptive marketing front for Big Pharma.

How much has Dr. Oz earned from his affiliation with RealAge? He isn’t saying.

Front man for Big Pharma?
In my view, Dr. Mehmet Oz. is a front man for Big Pharma and the vaccine industry. He’s pushing vaccines for his own personal financial gain while championing one of the largest internet Big Pharma marketing scams yet concocted.

Dr. Oz. stands to profit millions of dollars from helping creating demand for vaccines, and yet he does not disclose to his audience this huge, blatant conflict of interest. Sadly, by catapulting his career from her own show, Oprah has inadvertently unleashed a vaccine pusher onto the general public and given him influence over millions of people who may now be corralled into services like RealAge that seek to sell more drugs to unsuspecting consumers.

I respect Oprah. She’s an amazing achiever. But I don’t respect all the wannabe celebrity leeches who use her to launch their own careers and then exploit their newfound popularity for financial gain at the expense of the public.

Shame on Dr. Oz. for his financial conflicts of interest and his strong affiliation with the deadly pharmaceutical industry. Through his actions, Dr. Oz. has aligned himself with precisely the evil corporations that are destroying health in America today. Does the man have no shame?

He may not have any shame, but he does have 150,000 stock options that could be worth millions in the years ahead.

Inspired by the classic arcade basketball game of the 90’s, TECMO together with developer A.C.R.O.N.Y.M. Games has announced NBA Unrivaled, a retro st…

Check out the latest creation from the specialty design company, 100%. Despite having a name that’s really annoying to blog about, they do have some cool products for sale. What they don’t have for sale (quite yet) is this bracelet that cleverly conceals a digital wristwatch.

Not sure exactly how they do it, and power consumption might be an issue, but it certainly is a cool looking watch that looks more like an accessory then your bog standard watch.

No formal announcement on the release date or the price, but it should probably be out in the next few months and be in the sub-$400 range.

[via ablogtoread]

Despite lots of criticism over the plan, UK politicians are moving forward with demands that online service providers store and monitor certain types of internet communications. While the government will be compensating service providers for some of this (your tax dollars at work), it’s still a rather large burden on these service providers, and raises all sorts of privacy questions. Oh, and on top of all of that, we’ve already seen that law enforcement in the UK is struggling to cope with the fact that they’re already inundated with too much data. They don’t want more data, they need better data. Making service providers hang onto even more data doesn’t help the situation, it just opens up the potential for serious privacy invasion.

Permalink | Comments | Email This Story

It’s finally here! Call of Duty: Modern Warfare 2 is finally legally available in the US through special midnight release parties tonight. People can’t seem to stop tweeting about the game, as “Modern Warfare 2″ is now a trending topic on Twitter. Whether people have already gotten the game or are waiting in ridiculously long lines, people have something to say about CoD:MW2.

There is one common thing between all these tweets: everyone is excited to play this game. It’s already gotten two perfect scores and if what early players say is true, I’m sure more high scores are to come. I would add more to this, but let’s be honest, the lines on the West Coast are already two hundred deep and growing, and I need this game. Tonight.

What moderncat doesn’t love a nice homemade toy that helps reduce the impact on the landfill? Well, as soon as your cat reads this, he’ll be asking you for one of these toys from Etsy seller Marvelous Melissa. She makes two different kinds of eco-friendly cats toys: Three Blind Mice and darn!socks, both of which are extremely popular with the eco-conscious feline crowd.

Three Blind Mice are made with felted scraps of old wool sweaters rolled into little mice with organic catnip inside. Perfect for carrying and batting around. Darn!Socks are made from holey old socks, bound for the trash, but instead reincarnated as adorable mice, just the right size for bunny kicking. These guys are filled with organic catnip, a bit of recycled crinkly plastic, a few pistachio shells (for a good crunch), and recycled wool sweater lint. It doesn’t get any more eco-friendly than that!

Enter to Win! Bonus Giveaway, Five Winners, Winner’s Choice!

Marvelous Melissa is offering five winners each their choice of either a set of Three Blind Mice or a darn!socks cat toy. Please leave a comment on this post to enter. The five winners will be chosen in a random drawing on November 17 and notified via email. One entry per person. This giveaway is open to readers everywhere. Now that’s marvelous!

Good news for Motorola and Verizon, it looks like the Droid is a hit. The new phone is certainly living up to the hype, and seems to be the breakaway hit of this holiday season.

The former Digeo has managed to stay busy despite going through an acquisition by Arris. The company just went live with a slew of updates that show the company is serious about the DVR game. First and foremost is a new HD DVR model. This boy is almost exactly like the current Moxi HD DVR except it comes equipped with three tuners that will allow you to record three separate stations at one time off of a single multi-stream Cable Card. Take that, TiVo.

The new three-tuner model is perfect for the somewhat new Moxi Mate that will soon be able to utilize the tuners in a Moxi HD DVR for live TV viewing. Picture this: you’re streaming a recording from your main Moxi HD DVR onto the Moxi Mate in your bedroom but the wife fails asleep. This means you’re no longer obligated to watch Gray’s Anatomy and instead of switching to your TV’s tuner, the Moxi Mate will act just like a full size Moxi HD DVR and stream content live from one of the free tuners located in the full size Moxi HD DVR. You can even change the channel, view the guide, and timeshift live TV all over magic of Ethernet.

Up to two Moxi Mates can connect to one three-tuner DVR but can access live TV only when the main Moxi has a tuner available. If the tuners are in use, the user will be notified of the conflict and given the option to cancel the recording to free up the tuner. The necessary Moxi Mate software update will be available within the coming weeks along with an update to the Moxi HD DVR that tweaks the menu structure a bit.

Of course the new three tuner Moxi HD DVR can do the standard DVR functions too. Except this model allows you to record on three stations while watching a previously recorded program.

With the new model comes price drops. The two-tuner HD DVR is now $499 down from $799 and the standalone Moxi Mate is $299 instead of $399. The three-tuner model is only available in a bundle pack with either one or two Moxi Mates for $799 and $999, respectively. Just like before, there is no monthly fee with any of these products.

Arris, and formerly, Digeo has been on a roll ever since the Moxi HD DVR was released last December. This is the 3rd straight quarter that the company has significantly updated its Moxi HD DVR product line. TiVo hasn’t done that in years.

New Three-Tuner Moxi® HD DVR and Reduced Pricing for Moxi Multi-Room Packages Unwrapped for Holiday Season

Under ARRIS Ownership, Moxi Continues to Innovate and Deliver New Features to Consumers

SUWANEE, GA – November 10, 2009 – As part of its first product update since acquiring the award-winning Moxi product line from Digeo, Inc. in September, ARRIS (Nasdaq: ARRS) today announced the introduction of a three-tuner version of the Moxi HD DVR as well as reduced pricing for its two-tuner Moxi HD DVR and Moxi multi-room packages.

• The new three-tuner Moxi HD DVR, which allows for recording of three channels simultaneously while watching a fourth recorded program, is available in a Moxi HD DVR plus Moxi Mate bundle for $799 MSRP.
• The price of the two-tuner Moxi HD DVR introduced earlier this year has been reduced to $499 MSRP (formerly $799).
• In addition, ARRIS is introducing a three-room multi-room bundle option—a three-tuner Moxi HD DVR plus two Moxi Mates that collectively serve three rooms for $999.

The company also announced plans to deliver live TV on the Moxi Mate via the Moxi HD DVR. The Moxi HD DVR will receive the update automatically through a software download. Additionally, the price of the Moxi Mate has been reduced to $299 (formerly $399).

“We’ve heard from consumers that they love the Moxi products but are looking for different price and component options to serve their individual needs,” said Marc Beckwitt, VP of CPE Video Business Development, ARRIS. “The recent acquisition by ARRIS brings the market presence and leverage required to drive cost out of the product, and consequently, we’re able to offer these very competitive prices to consumers.”

ARRIS continues to stand by the commitment to deliver the Moxi “all in”, with no monthly or lifetime DVR service fees. Moxi also has no in-menu advertisements.

The Moxi HD DVR is designed to appeal to the most demanding digital cable entertainment enthusiasts. Some of its key attributes include:

• A native HD interface and Emmy® award-winning Moxi Menu
• Up to 75 hours of HD recording space or up to 300 hours at standard definition, and expandable to 6.5 Terabytes for up to 1000 hours of HD recording with an external eSATA drive
• Access to many Internet services consumers already use, such as Rhapsody®, Flickr® and online video from Netflix®, Hulu™, and YouTube™ via DLNA server software such as PlayOn™ (currently provided at no charge) running on their PC
• Multi-room viewing with the Moxi Mate and the ability to record three channels simultaneously while watching a fourth recorded program on the three-tuner version of the Moxi HD DVR
• Remote and mobile browser scheduling to set recordings while away from home moxi.com
• MoxiNet for full-screen web browsing and SupertickerTM —a ticker widget that provides information, such as weather, sports scores and news along the bottom of the screen

The Moxi HD DVR makes it effortless for consumers to discover, experience and share high definition media from their digital cable provider, PCs on the home network, and the Internet.

Also scheduled for release later this month are additional software upgrades to Moxi, which include new search and record option menus. These software updates will enable users to specify preferred record settings that can be applied to any new recorded TV shows or TV series. The new menu structure delivers easier access and better visibility related to the DVR function of the Moxi HD DVR, such as available hard drive space and other Moxi HD DVR related recording and scheduling functions.

Software upgrades, which have been delivered each quarter since unveiling the Moxi at CES in January 2009, continue to be delivered to the consumer automatically and at no charge.

Taking advantage of ARRIS e-tail infrastructure, the company is also introducing payment via major credit card instead of the PayPal option previously offered. The new Moxi pricing and bundle options are available now at www.moxi.com.

For more details, technical specifications and screen images of the Moxi HD DVR and Moxi Mate, please visit: www.moxi.com. You can also follow Moxi on Twitter at www.twitter.com/moxi_hd or on Facebook at www.facebook.com/moxi.hd.

Yup, that gigantic Dell box contained a huge color laser printer. But to my pleasant surprise, the 100 lbs 5130cdn isn’t nearly as boring and mundane as I thought it was going to be. I really don’t know if it’s the fastest printer in the world like Dell claims, but I do know that this printer could be a serious weapon in the hands of a comic book pirate. (I would like to think they exist)

Disclaimer: I don’t know jack about business-level printers. When Dell first asked me to look the world’s fastest color laser printer, I thought it was going to be a desktop model like Best Buy sells. Nope, the 5130cdn is a full scale, business printer with a monthly load throughput capacity of a 110,000 pages. This printer is serious business but for $1,549 I would expect nothing less.

I managed to get the printer set up after some issues with Windows 7. For some reason, this brand new printer doesn’t ship with Windows 7 drivers, instead I had share the printer on another computer and then the print speed wasn’t up to spec. But once Dell gave me the right drivers and assured me that I got a pre-production model and the retail version will have the compatible drivers, I was off to the races.

The printer is rated at 47ppm in both mono and color and I found those numbers to be accurate. With just a random text-only PDF, I was able to get about 39ppm when printing over a wireless network and exactly 47ppm via a direct USB connection. Even when the document has a splattering of color, the speed isn’t noticeably affected.

But let’s say you want to print a full-color comic book for some random reason. Just how fast is it then? Well, the 5130cdn managed to spit out the 38 pages in 1:38 as shown in the video above. Trust me, that’s fast considering each page is a full color image around 800KB in size. Try that with your inkjet and see what you get.

Dell has of course loaded this printer with a ton of new technology to get these results. It’s the first Dell printer to use ColorByDell, which is a total print quality solution that improves color saturation, sharpness, and print quality. Plus, the printer has a Cost Per Page of 1.04c per page for black and white, and 7.72c for color.

The 5130cdn is available starting today for $1,549, which includes a 3 year next business day on-site service contract. Let me warn you though, if you do buy this monster, its shipping weight is 120 lbs on a pallet and your wife won’t like it if it sits in the living room all evening.

Dell Launches World’s Fastest Color Laser Printer

3 New Commercial Printers Help Customers Boost Productivity & Lower TCO

ROUND ROCK, NOVEMBER 10, 2009 – Dell today announced three new commercial workgroup printers to help businesses of all sizes increase productivity and lower their total cost of printing. Printers available today include the Dell 5130cdn, the world’s fastest single function letter (LTR) size color laser printer, the Dell 7130cdn, Dell’s first LED color printer with tabloid size printing capability; and the Dell 3330dn, a single function monochrome laser printer for high performance class black and white printing. These new printers will be launched and available in Europe and the Middle East on November 24.

The Dell 5130cdn can print up to 47 single-side and 37.6 double-side LTR pages per minute (ppm) in both mono and color, making it the world’s fastest LTR size single–function color laser printer.  The 5130cdn also premiers ColorbyDell, a total print quality solution that delivers improved color saturation and image sharpness and outstanding print quality. This is enabled through a combination of a powerful new image enhancement algorithm, advanced toner technology and improvements in print engine design. The Dell5130cdn also brings significant energy and cost savings by using a new toner formulation that fuses at a lower temperature, enabling a remarkable Cost Per Page (CPP) of 1.04c for black and white and 7.72c for color print outs[i]. With a maximum duty cycle up to 110,000 pages a month, the Dell 5130cdn provides outstanding reliability and is available today in the US from $1,549 with 3 Year Next Business Day (NBD) Onsite Service after remote diagnosis[ii].

To help companies reign in the costs of their color printing, Dell also announced the availability of Dell ColorTrack Pro—a remote administration tool for IT administrators to centrally monitor and control access to color printing on the Dell 5130cdn. Designed for workgroup environments, Dell ColorTrack Pro manages user access at the server level, to more easily control printing and toner costs.

“With a school district as large as ours, it’s important that we provide students, faculty and staff access to quality technology,” said Tim McNeese, Information Systems Director of Williamson County Schools. “After installing the new Dell 5130cdn printers, we noticed a big difference in the quality and speed of the printouts. The great value and high production rate helps our schools run smoothly and collaboratively,” he added.

The Dell 7130cdn is Dell’s first LED-based color printer with the ability to print up to tabloid-size, high quality Pantone® approved color prints, for more accurate color reproduction. With its ability to bring professional quality color printing in-house with lower costs and improved printing options, the Dell 7130cdn includes a rich feature set, including numerous paper handling options, a powerful processor and enhanced memory. This allows the printer to print the first page (First Print Out Time) as quickly as 6.5 seconds in both mono and color. The Dell 7130cdn is available today in the US from $2,799 with 1 Year Next Business Day (NBD) Onsite Service after Remote Diagnosis[iii].

“Dell’s new commercial printers add to a compelling portfolio of business color and mono printers for organizations of all sizes,” said Keith Kmetz, Vice President of Hardcopy Peripherals Solutions and Services at IDC. “The Dell 5130cdn revolutionizes speed and usability. And its user-friendly appeal makes it attractive to organizations looking for high quality color output at a low total cost of ownership,” he added.

On the black and white printing front, Dell announced the Dell 3330dn, a single–function black and white performance printer that can print up to 40 pages per minute (ppm), with a monthly duty cycle up to 80,000 pages. Built for high performance printing needs, the Dell 3330dn packs work-horse reliability, and includes paper drawer and memory expansion capabilities that grow with increasing business demands, all in a compact desktop size. The Dell 3330dn is currently available from today in the US from $599 with 1 year Advanced Exchange Service.

“Dell has always focused on efficiency, reducing costs and increasing productivity for businesses of all sizes, and today we have extended that same winning formula to the printing world,” said Mike Arterbury, Global Director Commercial Software & Peripherals at Dell Inc. “Our portfolio of printers provides customers with valuable and affordable choices and lower cost of printing, saving them time – and real money!” he added.

“Dell’s complete lineup of laser printers provide customers with outstanding value, world class reliability and ease of use to help them achieve more with less, with minimum downtime and complexity,” said C. K. Lim, General Manager of Dell’s Global Imaging Business.

Dell printers are available direct from Dell and from Dell’s more than 50,000 partners worldwide.

Printer Specifications

	5130cdn Color Laser Printer	7130cdn Color Laser Printer	3330dn Mono Laser Printer
List price	US$ 1,549 (includes 3-yr NBD On-site Service after remote diagnosis)	US$ 2,799 with 1-yr NBD Onsite Service after remote diagnosis	US$599 with 1-yr NBD Advanced Exchange after remote diagnosis
Consumables type	Separated toner and drum unit	Separated toner and drum unit	Separated toner and drum unit
Print Speed (Letter)	Up to 47ppm in both mono and color (Actual print speed will vary with use)	Up to 35ppm (actual print speed will vary with use)	Up to 40ppm  (actual print speed will vary with use)
Duplex Print	Standard	Standard	Standard
Max. resolution	Up to 1200 dpi x 1200 dpi	Up to 1200 dpi x 1200 dpi	Up to 1200×1200 dpi / 2400 IQ
User interface	160 x 64 Mono Graphics backlit LCD text	128 x 64 Graphics backlit LCD text	4 line backlit LCD (text and graphics)
	3-button + 5-way cursor keypad	6-button cluster	20 buttons keypad
	1 LED: Status (green, yellow & red)	1 LED: Status (green, yellow & red)	1 two-tone LED
Processor	800 MHz	1 GHz	466 MHz
Connectivity	High-speed USB 2.0, Gigabit Ethernet	High-speed USB 2.0, Gigabit Ethernet	USB 2.0 (Hi speed), Parallel, 10/100 Ethernet
Print Language	PCL® 5c, 5e/6 Emulation: 81 fonts Adobe® PostScript® 3: 136 fonts	PCL® 5c,  PDF direct v1.4 , Adobe® PostScript® 3 Adobe® PostScript® 3	PCL® 5e, PCL 6, PCL XL, HBP (GDI), XPS (GDI) and PostScript® Level 3 Emulation
Paper input (std/max)	700 / 2900 sheets	600 / 2100 sheets	250 / 850 sheets (550tray+MPT)
Paper output (std/max)	500 / 1000 sheets	400 / 400 sheets	50 sheets
Multi-purpose input	150 sheet	100 sheet	150 sheets
Max. monthly duty cycle	Up to 110,000 pages	Up to 150,000 pages	Up to 80,000 pages
Size (W x D x H)	22.1” x 20.0” x 17.0”	25.2” x 26.2” x 15.7”	10.2″ x 16.6″ x 14.53″
Weight	99lbs (45kg)	145.2lbs (66 kg)	31.15 lb.

Related Links:

For more details, please go to www.dell.com/printers